Pharmaceutical companies are trying to undermine a decision of the Brazilian Supreme Court from 2021 which puts health ahead of private profit

At ManiFiesta, the fest of solidarity, Medics for the People sparked discussions about pressing problems in the health system in Belgium, offering people-centered, public alternatives

Dozens of scientists, health activists, and health officers in the EU are gathering support for building public capacities for pharmaceutical production and breaking ties with industry

Civil society in South Korea renewed its commitment to ensure universal access to medicines and public pharmaceutical production, building on decades of mobilization

Activists and academics discussed future of the access to medicines movement at the Global Summit on Intellectual Property and Access to Medicines in Istanbul at the end of July

Medics for the People has been providing primary health care to people in Belgium for more than 50 years. They recently launched a new mission statement outlining their main streams of work for the upcoming period

NewscClick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss the TRIPS waiver and the larger question of intellectual property rights and public health

We don’t face multiple separate crises. The system itself is the crisis and must be overcome, replaced and transformed.

The creation of the African Medicines Agency with the objective of maintaining European standards for medicines in the continent may hamper the supply of regular and economical versions of medicines in areas where access is already skewed 

Moderna’s filing for patents in South Africa puts a question mark on its intentions of honoring the pledge that it will not enforce patents during the pandemic. Activists fear that this may jeopardize the WHO’s technology sharing hub

During the Covid-19 pandemic, Pfizer has used every opportunity to maximize its profits, even if this meant reduced access to life-saving medical products for most of the world. The same is about to happen in the case of Paxlovid, the company’s Covid-19 oral treatment

The deliberate policy of big pharma and rich countries to leave large populations in poorer countries unvaccinated could plunge the world into another downturn